Submitted by: Submitted by marketresearchri
Views: 11
Words: 904
Pages: 4
Category: Business and Industry
Date Submitted: 05/10/2016 10:47 PM
Corneal Neovascularization Market Syndrome,
Treatment, Pipeline Review, H2 2015: Radiant Insights
Corneal Neovascularization - Pipeline Review, H2 2015
Summary
Global Markets Direct's, 'Corneal Neovascularization - Pipeline Review, H2 2015', provides an overview
of the Corneal Neovascularization's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Corneal
Neovascularization, complete with comparative analysis at various stages, therapeutics assessment by
drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with
latest updates, and featured news and press releases. It also reviews key players involved in the
therapeutic development for Corneal Neovascularization and special features on late-stage and
discontinued projects.
Access Full Report With TOC @ http://www.radiantinsights.com/research/cornealneovascularization-pipeline-review-h2-2015
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third
party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the
report undergoes periodic updation following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally, processes including live news &
deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to...